NCT00798473View on ClinicalTrials.gov

Zoledronate for Osteopenia in Pediatric Crohn's

PHASE3CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

September 30, 2007

Study Completion Date

November 30, 2008

Conditions
Crohn's DiseaseOsteopeniaOsteoporosis
Interventions
DRUG

zoledronic acid

Zoledronic acid 0.066 mg/kg (maximum 4 mg) given as a single intravenous infusion over ten minutes

OTHER

IV saline infusion

Trial Locations (1)

H3H 1P3

McGill University Health Center - Montreal Children's Hospital, Montreal

All Listed Sponsors
collaborator

Crohn's and Colitis Foundation

OTHER

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT00798473 - Zoledronate for Osteopenia in Pediatric Crohn's | Biotech Hunter | Biotech Hunter